LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 12 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $17,527,000 | +0.9% | 31,800,000 | 0.0% | 0.01% | -25.0% |
Q1 2020 | $17,367,000 | -27.2% | 31,800,000 | 0.0% | 0.01% | -20.0% |
Q4 2019 | $23,861,000 | +18.3% | 31,800,000 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $20,177,000 | -40.9% | 31,800,000 | 0.0% | 0.01% | -37.5% |
Q2 2019 | $34,119,000 | +6.2% | 31,800,000 | 0.0% | 0.02% | 0.0% |
Q1 2019 | $32,140,000 | -9.2% | 31,800,000 | 0.0% | 0.02% | -15.8% |
Q4 2018 | $35,409,000 | -25.0% | 31,800,000 | 0.0% | 0.02% | -9.5% |
Q3 2018 | $47,201,000 | -7.8% | 31,800,000 | 0.0% | 0.02% | -16.0% |
Q2 2018 | $51,179,000 | +24.1% | 31,800,000 | 0.0% | 0.02% | +13.6% |
Q1 2018 | $41,253,000 | -8.7% | 31,800,000 | 0.0% | 0.02% | -18.5% |
Q4 2017 | $45,171,000 | -14.3% | 31,800,000 | 0.0% | 0.03% | -32.5% |
Q3 2017 | $52,694,000 | -20.8% | 31,800,000 | 0.0% | 0.04% | -28.6% |
Q2 2017 | $66,503,000 | +12.0% | 31,800,000 | 0.0% | 0.06% | +3.7% |
Q1 2017 | $59,382,000 | +96.3% | 31,800,000 | +89.3% | 0.05% | +74.2% |
Q4 2016 | $30,248,000 | -20.4% | 16,800,000 | 0.0% | 0.03% | -18.4% |
Q3 2016 | $37,977,000 | +38.9% | 16,800,000 | +15.1% | 0.04% | +26.7% |
Q2 2016 | $27,333,000 | +86.4% | 14,600,000 | +60.4% | 0.03% | +66.7% |
Q1 2016 | $14,660,000 | +26.9% | 9,100,000 | +37.9% | 0.02% | +38.5% |
Q4 2015 | $11,554,000 | – | 6,600,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 5,250,000 | $4,410,000 | 0.30% |
WOLVERINE ASSET MANAGEMENT LLC | 6,000,000 | $5,475,000 | 0.04% |
MACKAY SHIELDS LLC | 30,000 | $26,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 320,000 | $252,000 | 0.00% |